Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 29,538 shares at $31.84 ($941K) on 2024-08-21, disclosed to the SEC on 2024-08-23.
Seasonal sale ($941k) by Chief Executive Officer — this insider has traded IMVT in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.84 | 14,470 | $461K | 49.0% |
| 2 | $31.84 | 14,470 | $461K | 49.0% |
| 3 | $32.32 | 598 | $19K | 2.1% |
| Total | $31.85 avg | 29,538 | $941K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |